- Home
- GASS vs ACRV Comparison
GASS vs ACRV Comparison
Compare GASS & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GASS
- ACRV
- Stock Information
- Founded
- GASS 2004
- ACRV 2018
- Country
- GASS Greece
- ACRV United States
- Employees
- GASS N/A
- ACRV N/A
- Industry
- GASS Marine Transportation
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- GASS Consumer Discretionary
- ACRV Health Care
- Exchange
- GASS Nasdaq
- ACRV Nasdaq
- Market Cap
- GASS 187.0M
- ACRV 203.9M
- IPO Year
- GASS 2005
- ACRV 2022
- Fundamental
- Price
- GASS $4.90
- ACRV $6.60
- Analyst Decision
- GASS
- ACRV Strong Buy
- Analyst Count
- GASS 0
- ACRV 5
- Target Price
- GASS N/A
- ACRV $22.40
- AVG Volume (30 Days)
- GASS 195.3K
- ACRV 63.5K
- Earning Date
- GASS 02-19-2025
- ACRV 11-13-2024
- Dividend Yield
- GASS N/A
- ACRV N/A
- EPS Growth
- GASS 33.66
- ACRV N/A
- EPS
- GASS 1.76
- ACRV N/A
- Revenue
- GASS $157,934,316.00
- ACRV N/A
- Revenue This Year
- GASS $16.12
- ACRV N/A
- Revenue Next Year
- GASS $0.12
- ACRV N/A
- P/E Ratio
- GASS $2.77
- ACRV N/A
- Revenue Growth
- GASS 3.82
- ACRV N/A
- 52 Week Low
- GASS $4.82
- ACRV $3.19
- 52 Week High
- GASS $8.84
- ACRV $11.90
- Technical
- Relative Strength Index (RSI)
- GASS 27.34
- ACRV 42.20
- Support Level
- GASS $4.82
- ACRV $6.56
- Resistance Level
- GASS $5.15
- ACRV $7.45
- Average True Range (ATR)
- GASS 0.17
- ACRV 0.47
- MACD
- GASS -0.02
- ACRV -0.00
- Stochastic Oscillator
- GASS 7.58
- ACRV 28.12
About GASS StealthGas Inc.
StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.